We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Transmedics Group Inc
7 own
8 watching
Current Price
$69.36
$1.49
(2.2%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,214.94M
52-Week High
70.1985
52-Week Low
10
Average Volume
0.3M
Dividend Yield
--
P/E Ratio
--
Market Capitalization2,214.94M52-Week High70.198552-Week Low10Average Volume0.3MDividend Yield--P/E Ratio--What does the Transmedics Group Inc do?
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Read More
How much money does Transmedics Group Inc make?
News & Events about Transmedics Group Inc.
Zolmax
12days ago
TransMedics Group, Inc. (NASDAQ:TMDX Get Rating) insider Tamer I. Khayal sold 5,558 shares of the companys stock in a transaction dated Friday, January 20th. The shares were sold at an average price of $65.21, for a total transaction of $362,437.18. Following the completion of the transaction, the ...
CNBC: Mad Money with Jim Cramer
16days ago
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed...
Zolmax
27days ago
TransMedics Group (NASDAQ:TMDX Get Rating) had its price objective raised by research analysts at Morgan Stanley from $54.00 to $63.00 in a report released on Friday, Benzinga reports. The firm presently has an equal weight rating on the stock. Morgan Stanleys price target would suggest a potential ...
Ticker Report
1month ago
TransMedics Group, Inc. (NASDAQ:TMDX Get Rating) has earned an average recommendation of Moderate Buy from the seven ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and five have ...
Zolmax
1month ago
TransMedics Group, Inc. (NASDAQ:TMDX Get Rating) VP John F. Carey sold 10,000 shares of the companys stock in a transaction on Friday, December 2nd. The shares were sold at an average price of $63.50, for a total value of $635,000.00. Following the transaction, the vice president now directly owns ...
Frequently Asked Questions
Frequently Asked Questions
What is Transmedics Group Inc share price today?
Can Indians buy Transmedics Group Inc shares?
How can I buy Transmedics Group Inc shares from India?
Can Fractional shares of Transmedics Group Inc be purchased?
What are the documents required to start investing in Transmedics Group Inc stocks?
What is today’s traded volume of Transmedics Group Inc?
What is today’s market capitalisation of Transmedics Group Inc?
What is the 52-Week High and Low Range of Transmedics Group Inc?
What percentage is Transmedics Group Inc down from its 52-Week High?
What percentage is Transmedics Group Inc up from its 52-Week Low?
Current Price
$69.36
$1.49
(2.2%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.